|
 |
 Click here to close window and return to the article.

|
|
CABG |
Drug group |
Heart Transplantation |
|
|
(n = 19) |
(n = 25) |
(n = 5) |
|
Sex |
Male |
Male |
Male |
|
Age (years) |
47±6.7 |
45.7±5.4 |
46.8±4.8 |
|
Angina pectoris: |
|
SMI |
10.2 |
0.0 |
0.0 |
|
II |
- |
11 |
63.0 |
|
III |
33.3 |
33 |
33.4 |
|
IV |
55.6 |
46 |
4.0 |
|
NYHA heart failure: |
|
III |
67 |
62 |
84 |
|
IV |
33 |
38 |
16 |
|
Number of MI |
1.74±0.28 |
2.0±0.1 |
1.9±04 |
|
Sinus rhythm |
100 |
84 |
83.7 |
|
AF |
0.0 |
16 |
16.3 |
Table 1. Clinical Characteristics of Patients with ICMP Designations: SMI = silent myocardial ischemia; FC = functional class; MI =myocardial infarction; AF = atrial fibrillation.
|
 |